Lois E. Bolcsak

436 total citations
11 papers, 349 citations indexed

About

Lois E. Bolcsak is a scholar working on Small Animals, Molecular Biology and Oncology. According to data from OpenAlex, Lois E. Bolcsak has authored 11 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Small Animals, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lois E. Bolcsak's work include Antifungal resistance and susceptibility (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Infectious Diseases and Mycology (2 papers). Lois E. Bolcsak is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Infectious Diseases and Mycology (2 papers). Lois E. Bolcsak collaborates with scholars based in United States, Canada and Poland. Lois E. Bolcsak's co-authors include Donald E. Nerland, Andrew S. Janoff, Christine E. Swenson, Christopher Cavanaugh, Ralph J. Bernacki, Amarnath Sharma, E. Mayhew, Paul A. Harmon, R.K. Bhamra and Troy H. Guthrie and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and International Journal of Cancer.

In The Last Decade

Lois E. Bolcsak

11 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lois E. Bolcsak United States 8 104 102 84 53 44 11 349
Hui Fan China 9 93 0.9× 171 1.7× 57 0.7× 52 1.0× 37 0.8× 21 371
Geetha Vasanthakumar United States 12 101 1.0× 186 1.8× 71 0.8× 24 0.5× 104 2.4× 21 499
Jingjing Yan China 14 66 0.6× 217 2.1× 91 1.1× 52 1.0× 59 1.3× 41 632
Pradeep K. Karla United States 11 107 1.0× 153 1.5× 103 1.2× 35 0.7× 45 1.0× 15 674
Chunling Jiang China 10 40 0.4× 181 1.8× 66 0.8× 62 1.2× 16 0.4× 30 501
Xiaowei Jia China 12 50 0.5× 90 0.9× 42 0.5× 56 1.1× 51 1.2× 32 384
Christiane Brassinne Belgium 10 59 0.6× 101 1.0× 73 0.9× 104 2.0× 12 0.3× 21 428
Yumiko Takeda Japan 12 40 0.4× 132 1.3× 69 0.8× 17 0.3× 21 0.5× 14 337
Gabriela Pastuch-Gawołek Poland 14 56 0.5× 215 2.1× 43 0.5× 39 0.7× 62 1.4× 47 466
Yicheng Li China 14 38 0.4× 197 1.9× 49 0.6× 38 0.7× 48 1.1× 41 489

Countries citing papers authored by Lois E. Bolcsak

Since Specialization
Citations

This map shows the geographic impact of Lois E. Bolcsak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois E. Bolcsak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois E. Bolcsak more than expected).

Fields of papers citing papers by Lois E. Bolcsak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois E. Bolcsak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois E. Bolcsak. The network helps show where Lois E. Bolcsak may publish in the future.

Co-authorship network of co-authors of Lois E. Bolcsak

This figure shows the co-authorship network connecting the top 25 collaborators of Lois E. Bolcsak. A scholar is included among the top collaborators of Lois E. Bolcsak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois E. Bolcsak. Lois E. Bolcsak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bhamra, R.K., et al.. (2003). Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats. Anti-Cancer Drugs. 14(3). 183–191. 2 indexed citations
2.
Bhamra, R.K., Lois E. Bolcsak, Imran Ahmad, et al.. (2003). Activity, pharmacokinetics and tissue distribution of TLC ELL-12 (liposomal antitumor ether lipid) in rats with transplantable, s.c. methylnitrosourea-induced tumors. Anti-Cancer Drugs. 14(6). 481–486. 5 indexed citations
4.
Adedoyin, Adedayo, Christine E. Swenson, Lois E. Bolcsak, et al.. (2000). A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections. Antimicrobial Agents and Chemotherapy. 44(10). 2900–2902. 40 indexed citations
5.
Williams, Penny, Hetty Waskin, Lois E. Bolcsak, & Christine E. Swenson. (1999). AMPHOTERICIN B CONCENTRATIONS IN AUTOPSY TISSUES OF ORGAN TRANSPLANT PATIENTS ADMINISTERED AMPHOTERICIN B LIPID COMPLEX INJECTION. Transplantation. 67(7). S93–S93. 8 indexed citations
6.
Sharma, Amarnath, E. Mayhew, Lois E. Bolcsak, et al.. (1997). Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. International Journal of Cancer. 71(1). 103–107. 112 indexed citations
7.
Bhamra, R.K., et al.. (1997). Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats. Antimicrobial Agents and Chemotherapy. 41(5). 886–892. 31 indexed citations
8.
Boni, Lawrence T., Walter R. Perkins, Sharma R. Minchey, et al.. (1990). Polymorphic phase behavior of alpha-tocopherol hemisuccinate. Chemistry and Physics of Lipids. 54(3-4). 193–203. 9 indexed citations
9.
Bolcsak, Lois E. & Donald E. Nerland. (1983). Inhibition of erythropoiesis by benzene and benzene metabolites. Toxicology and Applied Pharmacology. 69(3). 363–368. 33 indexed citations
10.
Bolcsak, Lois E. & Donald E. Nerland. (1983). Purification of mouse liver benzene dihydrodiol dehydrogenases.. Journal of Biological Chemistry. 258(12). 7252–7255. 25 indexed citations
11.
Bolcsak, Lois E., et al.. (1979). Composition of splenic T lymphocytes in allophenic mice. Cellular Immunology. 46(1). 213–218. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026